MedTrace Logo

Edwards Cardioband European Post-Market Study, MiBAND

NCT03600688 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-01-26

No results posted yet for this study

Summary

To demonstrate reduction of MR with durable performance and im-provements in functional status

Conditions

  • Mitral Regurgitation
  • Mitral Insufficiency
  • Mitral Repair
  • Mitral Valve
  • Annuloplasty
  • Edwards Cardioband

Interventions

DEVICE

Edwards Cardioband System

Transcatheter mitral valve repair

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Principal Investigators

  • Stephan Baldus, MD · Herzzentrum UniKlinik Köln

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-06
Primary Completion
2023-12-30
Completion
2023-12-31

Countries

  • Germany
  • Italy
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03600688 on ClinicalTrials.gov